SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274644-15-000040
Filing Date
2015-08-03
Accepted
2015-08-03 16:18:10
Documents
3
Period of Report
2015-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OCERA THERAPEUTICS 8-K EARNING RELEASE Q2 2015 ocera-form8xkxearningsrele.htm 8-K 27356
2 EXHIBIT 99.1 FINANCIAL RESULTS Q2 2015 oceratherapeuticsreportsse.htm EX-99.1 106004
3 OCERA LOGO oceratherapeuticsrepo_image2.jpg GRAPHIC 23227
  Complete submission text file 0001274644-15-000040.txt   166635
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 151022578
SIC: 2834 Pharmaceutical Preparations